Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Other Operating Expenses: 2022-2024

Historic Other Operating Expenses for Addex Therapeutics (ADXN) over the last 3 years, with Dec 2024 value amounting to $207,275.

  • Addex Therapeutics' Other Operating Expenses rose 1870.40% to $1.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.7 million, marking a year-over-year increase of 2897.18%. This contributed to the annual value of $207,275 for FY2024, which is 1684.05% up from last year.
  • As of FY2024, Addex Therapeutics' Other Operating Expenses stood at $207,275, which was up 1,684.05% from -$13,085 recorded in FY2023.
  • Over the past 5 years, Addex Therapeutics' Other Operating Expenses peaked at $305,651 during FY2022, and registered a low of -$13,085 during FY2023.
  • In the last 3 years, Addex Therapeutics' Other Operating Expenses had a median value of $207,275 in 2024 and averaged $166,614.
  • As far as peak fluctuations go, Addex Therapeutics' Other Operating Expenses crashed by 104.28% in 2023, and later soared by 1,684.05% in 2024.
  • Addex Therapeutics' Other Operating Expenses (Yearly) stood at $305,651 in 2022, then slumped by 104.28% to -$13,085 in 2023, then spiked by 1,684.05% to $207,275 in 2024.